Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Charles Theuer
12 Dec 2025
Director
Exercised, kept
9,333
$1.14
$10.64K
August J Moretti
15 May 2023
Chief Financial Officer
Exercised, kept
3,000
$9.41
$28.23K
August J Moretti
21 Dec 2022
Chief Financial Officer
Exercised, kept
3,000
$9.41
$28.23K
August J Moretti
12 Apr 2021
Chief Financial Officer
Exercised, kept
1,000
$9.41
$9.41K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 18
Sales straight out of an exercise 54
Sales at will 24
Transactions with no price 0
Shares from compensation/vesting 11,101,263
Sales filed before the plan box existed 22
History held since 17 Dec 2020